BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24518158)

  • 1. Lack of clinical association and effect of peripheral WBC counts on immune cell function test in kidney transplant recipients with T-cell depleting induction and steroid-sparing maintenance therapy.
    Sageshima J; Ciancio G; Chen L; Dohi T; El-Hinnawi A; Paloyo S; Gaynor JJ; Mattiazzi A; Guerra G; Kupin W; Roth D; Ruiz P; Burke GW
    Transpl Immunol; 2014 Mar; 30(2-3):88-92. PubMed ID: 24518158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection.
    Bhorade SM; Janata K; Vigneswaran WT; Alex CG; Garrity ER
    J Heart Lung Transplant; 2008 Sep; 27(9):990-4. PubMed ID: 18765191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune function assay (ImmuKnow) as a predictor of allograft rejection and infection in kidney transplantation.
    He J; Li Y; Zhang H; Wei X; Zheng H; Xu C; Bao X; Yuan X; Hou J
    Clin Transplant; 2013; 27(4):E351-8. PubMed ID: 23682828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased intracellular adenosine triphosphate level as an index to predict acute rejection in kidney transplant recipients.
    Wang XZ; Jin ZK; Tian XH; Xue WJ; Tian PX; Ding XM; Zheng J; Li Y; Jing X; Luo ZZ
    Transpl Immunol; 2014 Jan; 30(1):18-23. PubMed ID: 24211610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualized immune monitoring of cardiac transplant recipients by noninvasive longitudinal cellular immunity tests.
    Israeli M; Ben-Gal T; Yaari V; Valdman A; Matz I; Medalion B; Battler A; Sredni B; Kristt D; Klein T
    Transplantation; 2010 Apr; 89(8):968-76. PubMed ID: 20075792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of immune cell function monitoring in renal transplantation after Thymoglobulin induction therapy.
    Serban G; Whittaker V; Fan J; Liu Z; Manga K; Khan M; Kontogianni K; Padmanabhan A; Cohen D; Suciu-Foca N; Ratner L; Colovai AI
    Hum Immunol; 2009 Nov; 70(11):882-90. PubMed ID: 19664673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the risk of infection and rejection in Hispanic renal transplant recipients by means of an adenosine triphosphate release assay.
    Cadillo-Chávez R; de Echegaray S; Santiago-Delpín EA; Rodríguez-Trinidad AT; Camacho-Carrazo B; Alfaro T; Saavedra-Pozo M; Carrasquillo L; González-Caraballo ZA; Morales-Otero LA
    Transplant Proc; 2006 Apr; 38(3):918-20. PubMed ID: 16647510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Immuknow" to measurement of cell-mediated immunity in renal transplant recipients undergoing short-term evaluation.
    De Paolis P; Favarò A; Piola A; Martini F; Cristiana G; Agrati C; Iappelli M; Di Giulio S
    Transplant Proc; 2011 May; 43(4):1013-6. PubMed ID: 21620039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune cell function assay does not identify biopsy-proven pediatric renal allograft rejection or infection.
    Ryan CM; Chaudhuri A; Concepcion W; Grimm PC
    Pediatr Transplant; 2014 Aug; 18(5):446-52. PubMed ID: 24930482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte ATP immune cell function assay in pediatric renal transplants: is it useful?
    Vyas S; Roberti I
    Transplant Proc; 2011 Dec; 43(10):3675-8. PubMed ID: 22172824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of CD4+ function assessment (ViraCor-IBT ImmuKnow test) in lung recipients.
    Piloni D; Magni S; Oggionni T; Benazzo A; Stella G; Scudeller L; Morosini M; Cova E; Meloni F
    Transpl Immunol; 2016 Jul; 37():35-39. PubMed ID: 27095000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-transplant donor-specific T-cell alloreactivity is strongly associated with early acute cellular rejection in kidney transplant recipients not receiving T-cell depleting induction therapy.
    Crespo E; Lucia M; Cruzado JM; Luque S; Melilli E; Manonelles A; Lloberas N; Torras J; Grinyó JM; Bestard O
    PLoS One; 2015; 10(2):e0117618. PubMed ID: 25689405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit of immune monitoring in heart transplant patients using ATP production in activated lymphocytes.
    Kobashigawa JA; Kiyosaki KK; Patel JK; Kittleson MM; Kubak BM; Davis SN; Kawano MA; Ardehali AA
    J Heart Lung Transplant; 2010 May; 29(5):504-8. PubMed ID: 20133166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of immunosuppressive drug levels to predict T-cell reactivity in pediatric transplant patients.
    Sampson VB; Dunn SP; Rymeski B; Malatack J; Rong NH; Flynn L; Krueger LJ
    J Pediatr Surg; 2008 Jun; 43(6):1134-41. PubMed ID: 18558196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the ImmuKnow assay to evaluate the effect of alemtuzumab-depleting induction therapy on cell-mediated immune function after renal transplantation.
    Zhou H; Lin J; Chen S; Ma L; Qiu Z; Chen W; Zhang X; Zhang Y; Lin X
    Clin Exp Nephrol; 2013 Apr; 17(2):304-9. PubMed ID: 23053591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring cell-mediated immunity during immunosuppression reduction in heart transplant recipients with severe systemic infections.
    Weston MW; Rinde-Hoffman D; Lopez-Cepero M
    Clin Transplant; 2020 Mar; 34(3):e13809. PubMed ID: 32003048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative Cylex assay predicts rejection risk in patients with kidney transplant.
    Myslik F; House AA; Yanko D; Warren J; Caumartin Y; Rehman F; Jevnikar AM; Stitt L; Luke PP
    Clin Transplant; 2014 May; 28(5):606-10. PubMed ID: 24628326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular ATP production in CD4+ T cells as a predictor for infection and allograft rejection in trough-level guided pediatric liver transplant recipients under calcineurin-inhibitor therapy.
    Schulz-Juergensen S; Burdelski MM; Oellerich M; Brandhorst G
    Ther Drug Monit; 2012 Feb; 34(1):4-10. PubMed ID: 22210096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single time point immune function assay (ImmuKnow) testing does not aid in the prediction of future opportunistic infections or acute rejection.
    Huskey J; Gralla J; Wiseman AC
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):423-9. PubMed ID: 21088287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishing pediatric immune response zones using the Cylex ImmuKnow assay.
    Hooper E; Hawkins DM; Kowalski RJ; Post DR; Britz JA; Brooks KC; Turman MA
    Clin Transplant; 2005 Dec; 19(6):834-9. PubMed ID: 16313333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.